Cargando…

Radiomics Analysis Derived From LGE-MRI Predict Sudden Cardiac Death in Participants With Hypertrophic Cardiomyopathy

Objectives: To identify significant radiomics features derived from late gadolinium enhancement (LGE) images in participants with hypertrophic cardiomyopathy (HCM) and assess their prognostic value in predicting sudden cardiac death (SCD) endpoint. Method: The 157 radiomic features of 379 sequential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jie, Bravo, Laura, Zhang, Jinquan, Liu, Wen, Wan, Ke, Sun, Jiayu, Zhu, Yanjie, Han, Yuchi, Gkoutos, Georgios V., Chen, Yucheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702805/ https://www.ncbi.nlm.nih.gov/pubmed/34957254 http://dx.doi.org/10.3389/fcvm.2021.766287

Ejemplares similares

A systematic review for sudden cardiac death in hypertrophic cardiomyopathy patients with myocardial fibrosis: a CMR LGE study
por: Silva, Nackle J, et al.
Publicado: (2012)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
por: Dong, Yan, et al.
Publicado: (2021)

Incremental Values of T1 Mapping in the Prediction of Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy: A Comparison With Two Guidelines
por: Qin, Le, et al.
Publicado: (2021)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
por: Rostomian, Ara H., et al.
Publicado: (2020)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)
por: Avanesov, Maxim, et al.
Publicado: (2016)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

Variable myocardial interstitial expansion by T1 mapping within LGE area in infarction and hypertrophic cardiomyopathy
por: Maestrini, Viviana, et al.
Publicado: (2013)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Relationship between myocardial scar and hypertrophy by LGE CMR in hypertrophic cardiomyopathy patients with and without clinical events
por: Kino, Aya, et al.
Publicado: (2012)

Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy
por: Potluri, Rahul, et al.
Publicado: (2012)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy
por: Yang, Fuyao, et al.
Publicado: (2021)

Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis
por: Wang, Jie, et al.
Publicado: (2023)

Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy
por: Östman-Smith, Ingegerd, et al.
Publicado: (2010)

Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?
por: Reis, Liliana, et al.
Publicado: (2018)

The Value of Cardiac Magnetic Resonance Imaging in Identification of Rare Diseases Mimicking Hypertrophic Cardiomyopathy
por: Fang, Tingting, et al.
Publicado: (2021)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy on non-contrast cine-magnetic resonance images using machine learning-based radiomics
por: Jiang, Shu, et al.
Publicado: (2022)

Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non‐ischaemic dilated cardiomyopathy: a meta‐analysis
por: Wang, Jie, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy Mimicking Acute Anterior Myocardial Infarction Associated with Sudden Cardiac Death
por: Daralammouri, Y., et al.
Publicado: (2012)

Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score
por: Östman-Smith, Ingegerd, et al.
Publicado: (2017)

A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
por: Miron, Anastasia, et al.
Publicado: (2020)

Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy
por: Binder, M. Scott, et al.
Publicado: (2020)

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?
por: Östman-Smith, Ingegerd
Publicado: (2022)

Phenotypic diversity identified by cardiac magnetic resonance in a large hypertrophic cardiomyopathy family with a single MYH7 mutation
por: Wang, Jie, et al.
Publicado: (2018)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
por: Brendel, Jan M., et al.
Publicado: (2023)

High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy
por: Gommans, D. H. Frank, et al.
Publicado: (2017)

Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging
por: Śpiewak, Mateusz, et al.
Publicado: (2021)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance
por: Stankowski, Kamil, et al.
Publicado: (2023)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy
por: Kim, Eun Kyoung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3paeemvurlqc1dl506ersrkfbu